ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,660.56
-0.70%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Acrivon Therapeutics Inc (ACRV)

  7. Acrivon Therapeutics Inc (ACRV) 뉴스

ACRV Acrivon Therapeutics Inc

8.45
-0.02 (-0.24%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Acrivon Therapeutics Inc ACRV 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.02 -0.24% 8.45 13:00:01
개장가 저가 고가 종가 전일 종가
8.53 8.20 8.7794 8.46 8.47
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202405:01GLOBEAcrivon Therapeutics Reports Initial Positive Clinical Data..
17/04/202409:01GLOBEAcrivon Therapeutics to Host Corporate R&D Event..
10/04/202421:00GLOBEAcrivon Therapeutics Presents Data at AACR Annual Meeting..
09/04/202420:00GLOBEAcrivon Therapeutics Announces $130 Million Private..
28/03/202421:00GLOBEAcrivon Therapeutics Reports Fourth Quarter and Full Year..
07/03/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/03/202406:30GLOBEAcrivon Therapeutics to Present Data at AACR Annual Meeting..
04/03/202422:15EDGAR2Form 8-K - Current report
04/03/202422:00GLOBEAcrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA,..
27/02/202422:00GLOBEAcrivon Therapeutics to Participate in a Panel Discussion at..
17/02/202407:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202405:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202422:27EDGAR2Form 8-K - Current report
08/02/202422:00GLOBEAcrivon Therapeutics Appoints Seasoned Industry Executive..
06/02/202422:00GLOBEAcrivon Therapeutics to Present at the Oppenheimer 34th..
20/01/202406:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/01/202406:00GLOBEAcrivon Therapeutics Announces Inducement Grants Under..
08/01/202421:28EDGAR2Form 8-K - Current report
04/01/202422:00GLOBEAcrivon Therapeutics to Present at the 42nd Annual J.P...
18/12/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
09/12/202306:21EDGAR2Form 8-K - Current report
02/12/202306:35EDGAR2Form S-3 - Registration statement under Securities Act of..
28/11/202322:58DJNAcrivon Therapeutics Gets FDA's Breakthrough Designation for..
28/11/202322:00GLOBEAcrivon Therapeutics Announces FDA has Granted Breakthrough..
21/11/202322:00GLOBEAcrivon Therapeutics Announces Inducement Grant Under Nasdaq..
17/11/202309:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202309:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202309:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202309:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202309:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202309:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202323:12EDGAR2Form 8-K - Current report
09/11/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:01GLOBEAcrivon Therapeutics Reports Third Quarter 2023 Financial..
20/10/202308:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202321:00GLOBEAcrivon Therapeutics Presents Data Demonstrating..
29/09/202308:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/09/202308:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/09/202305:05GLOBEAcrivon Therapeutics Announces Inducement Grants Under..
20/09/202305:32GLOBEAcrivon Therapeutics to Highlight its ACR-368 OncoSignature..
06/09/202306:23EDGAR2Form 8-K - Current report
06/09/202305:05GLOBEAcrivon Therapeutics Announces ACR-2316, a Novel Dual WEE1..
30/08/202321:00GLOBEAcrivon Therapeutics to Participate in Two Investor..
24/08/202305:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
ACRV
Acrivon Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유